404 related articles for article (PubMed ID: 26635338)
1. Complementary, Selective PET Imaging of Integrin Subtypes α5β1 and αvβ3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin.
Notni J; Steiger K; Hoffmann F; Reich D; Kapp TG; Rechenmacher F; Neubauer S; Kessler H; Wester HJ
J Nucl Med; 2016 Mar; 57(3):460-6. PubMed ID: 26635338
[TBL] [Abstract][Full Text] [Related]
2. Variation of Specific Activities of 68Ga-Aquibeprin and 68Ga-Avebetrin Enables Selective PET Imaging of Different Expression Levels of Integrins α5β1 and αvβ3.
Notni J; Steiger K; Hoffmann F; Reich D; Schwaiger M; Kessler H; Wester HJ
J Nucl Med; 2016 Oct; 57(10):1618-1624. PubMed ID: 27151985
[TBL] [Abstract][Full Text] [Related]
3. In vivo biokinetic and metabolic characterization of the ⁶⁸Ga-labelled α5β1-selective peptidomimetic FR366.
D'Alessandria C; Pohle K; Rechenmacher F; Neubauer S; Notni J; Wester HJ; Schwaiger M; Kessler H; Beer AJ
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):953-963. PubMed ID: 26497698
[TBL] [Abstract][Full Text] [Related]
4. Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of (68)Ga-NOPO-c(RGDfK).
Simeček J; Notni J; Kapp TG; Kessler H; Wester HJ
Mol Pharm; 2014 May; 11(5):1687-95. PubMed ID: 24669840
[TBL] [Abstract][Full Text] [Related]
5. PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin.
Quigley NG; Steiger K; Hoberück S; Czech N; Zierke MA; Kossatz S; Pretze M; Richter F; Weichert W; Pox C; Kotzerke J; Notni J
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1136-1147. PubMed ID: 34559266
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.
Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W
Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906
[TBL] [Abstract][Full Text] [Related]
7. [(68)Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging αvβ3 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation.
Knetsch PA; Zhai C; Rangger C; Blatzer M; Haas H; Kaeopookum P; Haubner R; Decristoforo C
Nucl Med Biol; 2015 Feb; 42(2):115-22. PubMed ID: 25459110
[TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of early stages of rheumatoid arthritis by α5β1-integrin-targeted positron emission tomography.
Notni J; Gassert FT; Steiger K; Sommer P; Weichert W; Rummeny EJ; Schwaiger M; Kessler H; Meier R; Kimm MA
EJNMMI Res; 2019 Sep; 9(1):87. PubMed ID: 31501931
[TBL] [Abstract][Full Text] [Related]
9. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Characterization of 4
Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M
J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124
[TBL] [Abstract][Full Text] [Related]
11. Be spoilt for choice with radiolabelled RGD peptides: preclinical evaluation of ⁶⁸Ga-TRAP(RGD)₃.
Notni J; Pohle K; Wester HJ
Nucl Med Biol; 2013 Jan; 40(1):33-41. PubMed ID: 22995902
[TBL] [Abstract][Full Text] [Related]
12. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC
J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379
[TBL] [Abstract][Full Text] [Related]
13. PET-Based Human Dosimetry of the Dimeric αvβ3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis.
López-Rodríguez V; Galindo-Sarco C; García-Pérez FO; Ferro-Flores G; Arrieta O; Ávila-Rodríguez MA
J Nucl Med; 2016 Mar; 57(3):404-9. PubMed ID: 26585063
[TBL] [Abstract][Full Text] [Related]
14. In Vivo PET Imaging of the Cancer Integrin αvβ6 Using
Notni J; Reich D; Maltsev OV; Kapp TG; Steiger K; Hoffmann F; Esposito I; Weichert W; Kessler H; Wester HJ
J Nucl Med; 2017 Apr; 58(4):671-677. PubMed ID: 27980050
[TBL] [Abstract][Full Text] [Related]
15. [⁶⁸Ga]NS₃-RGD and [⁶⁸Ga] Oxo-DO3A-RGD for imaging α(v)β₃ integrin expression: synthesis, evaluation, and comparison.
Knetsch PA; Petrik M; Rangger C; Seidel G; Pietzsch HJ; Virgolini I; Decristoforo C; Haubner R
Nucl Med Biol; 2013 Jan; 40(1):65-72. PubMed ID: 23102540
[TBL] [Abstract][Full Text] [Related]
16.
Siitonen R; Peuhu E; Autio A; Liljenbäck H; Mattila E; Metsälä O; Käkelä M; Saanijoki T; Dijkgraaf I; Jalkanen S; Ivaska J; Roivainen A
J Nucl Med; 2019 Oct; 60(10):1380-1387. PubMed ID: 30850498
[TBL] [Abstract][Full Text] [Related]
17. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.
Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA
Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595
[TBL] [Abstract][Full Text] [Related]
18. A novel PET tracer for the imaging of αvβ3 and αvβ5 integrins in experimental breast cancer bone metastases.
Mühlhausen U; Komljenovic D; Bretschi M; Leotta K; Eisenhut M; Semmler W; Bäuerle T
Contrast Media Mol Imaging; 2011; 6(6):413-20. PubMed ID: 22162137
[TBL] [Abstract][Full Text] [Related]
19. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
[TBL] [Abstract][Full Text] [Related]
20. [(68)Ga]NODAGA-RGD - Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis.
Haubner R; Finkenstedt A; Stegmayr A; Rangger C; Decristoforo C; Zoller H; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2005-13. PubMed ID: 27164900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]